We are live on
!
Find out more
HBK Investments Portfolio holdings
AUM
$10.3B
Turnover
52.97%
1-Year Est. Return
67.69%
This Fund
S&P 500
This Quarter
Est. Return
+17.33%
1 Year Est. Return
+67.69%
3 Year Est. Return
+191.59%
5 Year Est. Return
+445.48%
10 Year Est. Return
+2,540.16%
AUM
$10.4B
AUM Growth
+$2.53B
(+32%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
59.14%
Holding
804
New
199
Increased
164
Reduced
169
Closed
151
Avg Time Held Equity + Options
0.5
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment Corporation
CZR
|
+$367M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$259M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$109M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$86.7M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$71.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.57B |
| 2 |
Petrobras Class A
PBR.A
|
+$103M |
| 3 |
Takeda Pharmaceutical
TAK
|
+$45.4M |
| 4 |
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
+$25.2M |
| 5 |
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.48% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 6.42% |
| 4 | Technology | 6% |
| 5 | Communication Services | 2.24% |
Similar funds
BSL
HBK Investments's Q4 2019 Portfolio in Review
As of Q4 2019, HBK Investments held 804 positions worth $10.4B, up 32% from $7.82B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
HBK Investments withdrew a net $1.4B in Q4 2019, closing 151 positions and reducing 169 holdings. Its most notable exit was Celgene Corp, an estimated $1.57B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 53% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, HBK Investments opened a new position in Medicines Co worth $330M.
- HBK Investments's largest Q4 2019 buy was Medicines Co: 3,880,000 shares worth $330M.
- HBK Investments added most to Caesars Entertainment Corporation in Q4 2019, an estimated $367M increase.
- HBK Investments's biggest Q4 2019 reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, cutting an estimated $25.2M.
- HBK Investments fully exited Celgene Corp in Q4 2019, selling an estimated $1.57B.
- HBK Investments's ten largest holdings make up 59% of its $10.4B portfolio in Q4 2019.
- HBK Investments opened 199 new positions and closed 151 in Q4 2019.
- HBK Investments's portfolio value rose 32% quarter-over-quarter to $10.4B.
Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.